DAPT Safer With Switch from P2Y12 Blockers Early After Stenting (CME/CE)
(MedPage Today) -- Substituting in clopidogrel after a month cuts bleeding risk, trial says (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 16, 2017 Category: Cardiology Source Type: news
Ischemic Outcomes Don ’ t Vary With Gender in ACS Patients
No difference by gender for ACS patients undergoing PCI receiving clopidogrel, prasugrel, or ticagrelor (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 4, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news
Plavix (Clopidogrel Bisulfate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 28, 2017 Category: Drugs & Pharmacology Source Type: news
Platelet Function Testing Important With Pipeline Embolization Platelet Function Testing Important With Pipeline Embolization
Identification of patients who will be poor responders to antiplatelet therapy with clopidogrel can help avoid thromboembolic complications after flow diversion procedures for intracranial aneurysm.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 26, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Major Bleeding Risk From Drugs Similar in Elderly
Elderly taking aspirin, clopidogrel have major bleeding similar to that seen with oral anticoagulants (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 17, 2017 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Neurology, Nursing, Oncology, Pharmacy, Journal, Source Type: news
Are Blood Thinners Overused in Patients With Irregular Heartbeat?
FRIDAY, March 17, 2017 -- Many people living with the heart rhythm disorder known as atrial fibrillation may be taking unneeded blood thinners, a new study suggests.
These blood thinners, which include aspirin, Plavix and warfarin, are believed to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 17, 2017 Category: Journals (General) Source Type: news
TARDIS: Triple Antiplatelet Therapy No Benefit in Stroke, TIA TARDIS: Triple Antiplatelet Therapy No Benefit in Stroke, TIA
Triple antiplatelet therapy was not superior to guideline-recommended aspirin/dipyridamole or clopidogrel alone to prevent recurrent stroke in patients with recent stroke or TIA in the TARDIS trial.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 24, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Ticagrelor More Effective Than Clopidogrel in Some Cardiac Arrest Survivors Ticagrelor More Effective Than Clopidogrel in Some Cardiac Arrest Survivors
In comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention (PCI) and hypothermia, ticagrelor results in faster and stronger platelet inhibition compared to clopidogrel, researchers in Slovenia say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 30, 2016 Category: Consumer Health News Tags: News Source Type: news
Kengreal Sans GPI Safe in PCI, With Less Bleeding (CME/CE)
(MedPage Today) -- Only TIMI bleeds differed from Plavix-GPI combo in meta-analysis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 1, 2016 Category: Cardiology Source Type: news
Cangrelor Sans GPI Safe in PCI, With Less Bleeding (CME/CE)
(MedPage Today) -- Only TIMI bleeds differed from Plavix-GPI combo in meta-analysis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 1, 2016 Category: Cardiology Source Type: news
Breaking News from AHA 2016: Genetic Risk & Healthy Lifestyle, Ticagrelor vs. Clopidogrel in PAD, Targeting PCSK9 (FREE)
By the Editors
This week, NEJM Journal Watch is bringing you coverage of breaking news from the American Heart Association ' s Scientific Sessions in New Orleans. Take a look:Genetic Risk and Healthy Lifestyle: A healthy lifestyle can mitigate high genetic risk for coronary artery disease, according to an analysis of data … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 13, 2016 Category: Primary Care Source Type: news
EUCLID: Ticagrelor, Clopidogrel in PAD Similar for CV Events EUCLID: Ticagrelor, Clopidogrel in PAD Similar for CV Events
Those getting ticagrelor had fewer ischemic strokes, but that was only a part of the primary end point. It might have been related to the drug ' s effects on blood pressure, says an expert.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2016 Category: Consumer Health News Tags: Cardiology News Source Type: news
AHA: More Potent Antiplatelet Agent Not Better for PAD (CME/CE)
(MedPage Today) -- Ticagrelor no better than clopidogrel in EUCLID trial (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - November 13, 2016 Category: Geriatrics Source Type: news
CardioBrief: Ticagrelor No Better Than Clopidogrel in PAD
(MedPage Today) -- Top-line results from EUCLID trial announced ahead of AHA meeting (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 4, 2016 Category: Cardiology Source Type: news
Why 5,000 People Are Suing Over Plavix
Legal action is apparently moving forward involving lawsuits filed by thousands of people who say they suffered serious injuries by taking the once-heralded blood-thinning drug Plavix.
The California Supreme Court ruled late last month that eight product liability lawsuits against Plavix manufacturer Bristol-Myers Squibb and Plavix distributor McKesson Corporation can proceed in San Francisco Superior Court.
Those eight cases involved 678 plaintiffs. They may soon be joined by a multitude of other cases, involving about 5,000 plaintiffs, that have been filed around the country.
There is no word yet on whether Bristol-My...
Source: Healthy Living - The Huffington Post - September 13, 2016 Category: Consumer Health News Source Type: news
